Literature DB >> 8989586

Cloning of the mucosal addressin MAdCAM-1 from human brain: identification of novel alternatively spliced transcripts.

E Leung1, J Greene, J Ni, L G Raymond, K Lehnert, R Langley, G W Krissansen.   

Abstract

The mucosal addressin cell adhesion molecule-1 (MAdCAM-1), expressed selectively on high endothelial venules (HEV) and lamina propria venules, directs lymphocyte traffic by binding the lymphocyte Peyer's patch adhesion molecule-1 (LPAM-1, alpha 4 beta 7). Full-length DNA encoding human MAdCAM-1 was obtained by combining sequences from an expressed sequence tag (EST) identified in an early stage human brain cDNA library, a polymerase chain reaction-derived clone, and a MAdCAM-1 genomic clone. The deduced amino acid sequence revealed an 18 amino acid signal peptide, two N-terminal immunoglobulin (Ig)-like domains conserved (59-65%) in sequence with those of the mouse homologue, an 86 amino acid mucin-like region rich in serine-threonine residues, a 20 amino acid transmembrane domain and a 43 amino acid charged cytoplasmic domain. No counterpart to the third IgA-like domain of mouse MAdCAM-1 was present; however, the serine-threonine-rich mucin domain was extended as two distinguishable major and minor mucin regions unrelated to the mouse domain. The major domain is formed from six tandem repeats of an eight amino acid sequence having the MUC-2-related consensus DTTSPEP/SP. Human MAdCAM-1 mRNA transcripts were restricted to small intestine, colon, spleen, pancreas and brain. Alternatively spliced MAdCAM-1 variants were identified that lack parts of the second Ig domain and all or part of the major mucin domain, indicating that the function of this vascular addressin is regulated by extensive modifications to its multi-domain structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989586     DOI: 10.1038/icb.1996.81

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  7 in total

1.  Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.

Authors:  Natalia Guerra-Pérez; Ines Frank; Filippo Veglia; Meropi Aravantinou; Diana Goode; James L Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

2.  Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.

Authors:  J U Igietseme; J L Portis; L L Perry
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Glycosylation in immune cell trafficking.

Authors:  Markus Sperandio; Christian A Gleissner; Klaus Ley
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

4.  Mucosal addressin cell adhesion molecule-1 of rhesus macaques: molecular cloning, expression, and alteration after viral infection.

Authors:  Yue Wang; Wen-Rong Yao; Jia-Zhong Duan; Wei Xu; Gui-Bo Yang
Journal:  Dig Dis Sci       Date:  2014-05-15       Impact factor: 3.199

5.  CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis.

Authors:  Rachel Allavena; Suzanna Noy; Marcus Andrews; Nick Pullen
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

6.  MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis.

Authors:  Kristina Kuhbandner; Anna Hammer; Stefanie Haase; Elisa Terbrack; Alana Hoffmann; Angela Schippers; Norbert Wagner; Rehana Z Hussain; William A Miller-Little; Andrew Y Koh; Joshua S Stoolman; Benjamin M Segal; Ralf A Linker; Olaf Stüve
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

7.  Recruitment of α4β7 monocytes and neutrophils to the brain in experimental colitis is associated with elevated cytokines and anxiety-like behavior.

Authors:  Quentin J Pittman; Mark G Swain; Keith A Sharkey; Nina L Cluny; Kewir D Nyuyki; Wagdi Almishri; Lateece Griffin; Benjamin H Lee; Simon A Hirota
Journal:  J Neuroinflammation       Date:  2022-04-04       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.